Effects of the diabetes linked TCF7L2 polymorphism in a representative older population

BMC Medicine

Volumn 4, Issue , 2006, Pages

  Melzer, David ^a   Murray, Anna ^a   Hurst, Alison J ^a   Weedon, Michael N ^a   Bandinelli, Stefania ^b   Corsi, Anna Maria ^c,g   Ferrucci, Luigi ^d   Paolisso, Guiseppe ^e   Guralnik, Jack M ^f   Frayling, Timothy M ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b CNR   (Italy)

^c Tuscany Regional Health Agency   (Italy)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f NATIONAL INSTITUTE ON AGING   (United States)

^g UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7 LIKE 2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGED; ALLELE; ARTICLE; CONFIDENCE INTERVAL; CREATININE CLEARANCE; DEMENTIA; DIABETIC RETINOPATHY; DIET RESTRICTION; FEMALE; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HETEROZYGOTE; HUMAN; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; POPULATION RESEARCH; PREVALENCE; SCORING SYSTEM; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; AGING; BODY SIZE; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN; ITALY; LIPIDS; MALE; POLYMORPHISM, GENETIC; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 33846666328     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-4-34     Document Type: Article

References (31)

1. Wray LA Ofstedal MB Langa KM Blaum CS The effect of diabetes on disability in middle-aged and older adults J Gerontol A Biol Sci Med Sci 2005 60 1206-1211 16183964
2. Beckman JA Creager MA Libby P Diabetes and atherosclerosis: epidemiology, pathophysiology, and management JAMA 2002 287 2570-2581 10.1001/jama.287.19.2570 12020339
3. Costa J Borges M David C Vaz Carneiro A Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: Meta-analysis of randomised controlled trials BMJ 2006 332 1115-1124 1459619 16585050 10.1136/bmj.38793.468449.AE
4. Grant SF Thorleifsson G Reynisdottir I Benediktsson R Manolescu A Sainz J Helgason A Stefansson H Emilsson V Helgadottir A Styrkarsdottir U Magnusson KP Walters GB Palsdottir E Jonsdottir T Gudmundsdottir T Gylfason A Saemundsdottir J Wilensky RL Reilly MP Rader DJ Bagger Y Christiansen C Gudnason V Sigurdsson G Thorsteinsdottir U Gulcher JR Kong A Stefansson K Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes Nat Genet 2006 38 320-323 10.1038/ ng1732 16415884
5. Florez JC Jablonski KA Bayley N Pollin TI de Bakker PI Shuldiner AR Knowler WC Nathan DM Altshuler D the Diabetes Prevention Program Research Group TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program N Engl J Med 2006 355 241 250 10.1056/ NEJMoa062418 16855264 1762036
6. Cauchi S Meyre D Dina C Choquet H Samson C Gallina S Balkau B Charpentier G Pattou F Stetsyuk V Scharfmann R Staels B Frühbeck G Froguel P Transcription factor TCF7L2 genetic study in the French population: Expression in human {beta}-cells and adipose tissue and strong association with type 2 diabetes Diabetes 2006 55 2903-2908 10.2337/db06-0474 17003360
7. Saxena R Gianniny L Burtt NP Lyssenko V Giuducci C Sjogren M Florez JC Almgren P Isomaa B Orho-Melander M Lindblad U Daly MJ Tuomi T Hirschhorn JN Ardlie KG Groop LC Altshuler D Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals Diabetes 2006 55 2890-2895 10.2337/db06-0381 17003358
8. Damcott CM Pollin TI Reinhart LJ Ott SH Shen H Silver KD Mitchell BD Shuldiner AR Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: Replication and evidence for a role in both insulin secretion and insulin resistance Diabetes 2006 55 2654-2659 10.2337/db06-0338 16936218
9. Scott LJ Bonnycastle LL Willer CJ Sprau AG Jackson AU Narisu N Duren WL Chines PS Stringham HM Erdos MR Valle TT Tuomilehto J Bergman RN Mohlke KL Collins FS Boehnke M Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample Diabetes 2006 55 2649-2653 10.2337/db06-0341 16936217
10. Zhang C Qi L Hunter DJ Meigs JB Manson JE van Dam RM Hu FB Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men Diabetes 2006 55 2645-2648 10.2337/db06-0643 16936216
11. Groves CJ Zeggini E Minton J Frayling TM Weedon MN Rayner NW Hitman GA Walker M Wiltshire S Hattersley AT McCarthy MI Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk Diabetes 2006 55 2640-2644 10.2337/db06-0355 16936215
12. Sackett DL Haynes RB The architecture of diagnostic research BMJ 2002 324 539-541 1122451 11872558 10.1136/bmj.324.7336.539
13. Hattersley AT Pearson ET Minireview: Pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes Endocrinology 2006 147 2657-2663 10.1210/en.2006-0152 16556760
14. Ferrucci L Bandinelli S Benvenuti E Di Iorio A Macchi C Harris TB Guralnik JM Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study JAGS 2000 48 1618-1625
15. Zuliani G Volpato S Ble A Bandinelli S Corsi AM Lauretani F Paolisso G Fellin R Ferrucci L High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: The InChianti study Atherosclerosis 2006 16787648
16. Ferrucci L Guralnik JM Woodman RC Bandinelli S Lauretani F Corsi AM Chaves P Ershler W Longo D Proinflammatory state and circulating erythropoietin in persons with and without anemia Am J Med 2005 118 1288 10.1016/j.amjmed.2005.06.039 16271918
17. Kahn R Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 1997 20 1183-1197 9203460
18. Kahn R Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 2003 26 3160-3167 14578255
19. Ble A Fink JC Woodman RC Klausner MA Windham BG Guralnik JM Ferrucci L Renal function, erythropoietin, and anemia of older persons: The InCHIANTI study Arch Intern Med 2005 165 2222-2227 10.1001/ archinte.165.19.2222 16246987
20. National Institutes of Health Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary (NIH publ. no. 01-3670) Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute 2001
21. Weedon MN McCarthy MI Hitman G Walker M Groves CJ Zeggini E Rayner NW Shields B Owen KR Hattersley AT Frayling TM Combining information from common type 2 diabetes risk polymorphisms improves disease prediction PLoS Med 2006 3 10 e374 1584415 17020404 10.1371/journal.pmed.0030374
22. Biessels GJ Staekenborg S Brunner E Brayne C Scheltens P Risk of dementia in diabetes mellitus: A systematic review Lancet Neurology 2006 5 64-74 10.1016/S1474-4422(05)70284-2 16361024
23. Elahi D Muller DC Egan JM Andres R Veldhuis J Meneilly GS Glucose tolerance, glucose utilization and insulin secretion in ageing Novartis Foundation Symposium 2002 242 222-246 11855690
24. Turner RC Millns H Neil HAW Stratton IM Manley SE Matthews DR Holman RR Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) BMJ 1998 316 823-828 28484 9549452
25. Betteridge DJ Diabetic dyslipidaemia: Past, present and future Practical Diabetes International 2004 21 78-85 10.1002/pdi.593
26. Hobbs FR Reducing cardiovascular risk in diabetes: Beyond glycemic and blood pressure control Int J Cardiology 2006 110 137-145 10.1016/ j.ijcard.2005.09.011
27. Aiello LM Perspectives on diabetic retinopathy Am J Ophthalmol 2003 136 122-135 10.1016/S0002-9394(03)00219-8 12834680
28. Raptis AE Viberti G Pathogenesis of diabetic nephropathy Exp Clin Endocrinol Diabetes 2001 109 S424-S437 10.1055/s-2001-18600 11460589
29. Sheetz MJ King GL Molecular understanding of hyperglycemia's adverse effects for diabetic complications JAMA 2002 288 2579-2588 10.1001/ jama.288.20.2579 12444865
30. Turner R Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 1998 352 837-853 10.1016/ S0140-6736(98)07019-6 9742976
31. Setter SM Campbell RK Cahoon CJ Biochemical pathways for microvascular complications of diabetes mellitus Ann Pharmacother 2003 37 1858-1866 10.1345/aph.1D002 14632543